Dr. Gabriele Casirati is a hematologist and instructor at Boston Children’s Hospital and Dana-Farber Cancer Institute. He specializes in immune engineering and novel gene editing strategies, with a focus on enhancing targeted immunotherapies, hematopoietic stem cell transplantation and gene therapy. Dr. Casirati’s research has contributed to the development of epitope editing approaches aimed at making bone marrow transplants and CAR-T cell therapies safer and more effective.

Gabriele Casirati received his Medicine degree from Università degli Studi di Milano (Italy), completed his hematology residency at Università Vita-Salute San Raffaele, Milan, and received a Ph.D. in Molecular and Translational Medicine from Università Milano-Bicocca.